Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2. Disitamab can be used in the synthesis of Disitamab vedotin )[1].
Disitamab(27 mg/kg;i.v.;一次;5 mL/kg)对猴子没有显着毒性[1]。
[1]. Jiang J, et al. Preclinical safety profile of disitamab vedotin:a novel anti-HER2 antibody conjugated with MMAE. Toxicol Lett. 2020;324:30-37.
















